Literature DB >> 20599626

Structure-mutagenicity relationship of kaurenoic acid from Xylopia sericeae (Annonaceae).

B C Cavalcanti1, J R O Ferreira, D J Moura, R M Rosa, G V Furtado, R R Burbano, E R Silveira, M A S Lima, C A G Camara, J Saffi, J A P Henriques, V S N Rao, L V Costa-Lotufo, M O Moraes, C Pessoa.   

Abstract

Kaurane diterpenes are considered important compounds in the development of new highly effective anticancer chemotherapeutic agents. Genotoxic effects of anticancer drugs in non-tumour cells are of special significance due to the possibility that they induce secondary tumours in cancer patients. In this context, we evaluated the genotoxic and mutagenic potential of the natural diterpenoid kaurenoic acid (KA), i.e. (-)-kaur-16-en-19-oic acid, isolated from Xylopia sericeae St. Hill, using several standard in vitro and in vivo protocols (comet, chromosomal aberration, micronucleus and Saccharomyces cerevisiae assays). Also, an analysis of structure-activity relationships was performed with two natural diterpenoid compounds, 14-hydroxy-kaurane (1) and xylopic acid (2), isolated from X. sericeae, and three semi-synthetic derivatives of KA (3-5). In addition, considering the importance of the exocyclic double bond (C16) moiety as an active pharmacophore of KA cytotoxicity, we also evaluated the hydrogenated derivative of KA, (-)-kauran-19-oic acid (KAH), to determine the role of the exocyclic bond (C16) in the genotoxic activity of KA. In summary, the present study shows that KA is genotoxic and mutagenic in human peripheral blood leukocytes (PBLs), yeast (S. cerevisiae) and mice (bone marrow, liver and kidney) probably due to the generation of DNA double-strand breaks (DSB) and/or inhibition of topoisomerase I. Unlike KA, compounds 1-5 and KAH are completely devoid of genotoxic and mutagenic effects under the experimental conditions used in this study, suggesting that the exocyclic double bond (C16) moiety may be the active pharmacophore of the genetic toxicity of KA. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599626     DOI: 10.1016/j.mrgentox.2010.06.010

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

1.  Kaurenic acid: Evaluation of the in vivo and in vitro antitumor activity on murine melanoma.

Authors:  Miriam C Sosa-Sequera; Miguel Chiurillo; Jaime Moscoso; Josefina Dolinar; Omar Suarez; Natalia Neira; Hernan Mendoza; María Rivero-Paris
Journal:  Indian J Pharmacol       Date:  2011-11       Impact factor: 1.200

2.  Pharmacokinetic Profile of Kaurenoic Acid after Oral Administration of Araliae Continentalis Radix Extract Powder to Humans.

Authors:  Eun-Jeong Choi; Go-Wun Choi; Seung-Jeong Yang; Yong-Bok Lee; Hea-Young Cho
Journal:  Pharmaceutics       Date:  2018-12-01       Impact factor: 6.321

3.  A kinetic study of the main guaco metabolites using syrup formulation and the identification of an alternative route of coumarin metabolism in humans.

Authors:  João Cleverson Gasparetto; Rosângela Gonçalves Peccinini; Thais Martins Guimarães de Francisco; Letícia Bonâncio Cerqueira; Francinete Ramos Campos; Roberto Pontarolo
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.